Shares of Sun Pharmaceutical Industries tumbled more than 4% to Rs 1,643.60 on Friday after The Economic Times reported that the pharma major has submitted a $12-billion binding offer for Organon & Co., entering the final stage of its most ambitious overseas acquisition bid. The stock emerged as the top loser on the Sensex and…
January 23, 2026January 23, 2026 Shares of Sun Pharma Industries Ltd rose 0.75% to touch a day’s high of Rs 1,648.90 on 23rd January. This happened after the company announced that it had received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic…
July 25, 2025July 25, 2025 Shares of Sun Pharmaceutical Industries Ltd are trading flat after touching a day’s high of Rs 1,700.10 on 25th July, following the announcement that its subsidiaries, Sun Pharmaceutical Industries, Inc. (SPII) and Taro Pharmaceuticals U.S.A., Inc. (Taro), have entered into a settlement agreement in…
Pharma major Sun Pharma is expected to report healthy revenue growth during the second quarter, driven by its domestic business, which benefits from favorable seasonality and growing volumes. Revenue from operations is likely to jump 10% year-on-year (YoY), according to the average estimate of four brokerages. Meanwhile, net profit for the quarter is projected to…